ORIC logo

ORIC
ORIC Pharmaceuticals Inc

934
Mkt Cap
$916.13M
Volume
1.26M
52W High
$14.93
52W Low
$4.54
PE Ratio
-6.18
ORIC Fundamentals
Price
$8.85
Prev Close
$8.81
Open
$8.80
50D MA
$10.94
Beta
1.41
Avg. Volume
2.48M
EPS (Annual)
-$1.47
P/B
2.20
Rev/Employee
$0.00
$444.11
Loading...
Loading...
News
all
press releases
Citigroup Lowers Oric Pharmaceuticals (NASDAQ:ORIC) Price Target to $16.00
Citigroup lowered their price objective on shares of Oric Pharmaceuticals from $17.00 to $16.00 and set a 'buy' rating on the stock in a research report on Tuesday...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Oric Pharmaceuticals (NASDAQ:ORIC) Announces Quarterly Earnings Results, Misses Estimates By $0.03 EPS
Oric Pharmaceuticals (NASDAQ:ORIC - Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.34) earnings per share for the quarter, missing analysts' consensus estimates of ($0.31) by ($0.03...
MarketBeat·5d ago
News Placeholder
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Given Consensus Rating of "Moderate Buy" by Brokerages
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the fourteen ratings firms that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, two have assigned...
MarketBeat·8d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC Pharmaceuticals, Inc.- ORIC
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC Pharmaceuticals, Inc.- ORIC INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC...
PR Newswire·9d ago
News Placeholder
Oric Pharmaceuticals (ORIC) to Release Earnings on Monday
Oric Pharmaceuticals (NASDAQ:ORIC) will be releasing its Q1 2026 earnings before the market opens on Monday, May 4. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-4-oric-pharmaceuticals-inc-stock...
MarketBeat·13d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC Pharmaceuticals, Inc.- ORIC
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC Pharmaceuticals, Inc.- ORIC INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC...
PR Newswire·24d ago
News Placeholder
ORIC Investors Have Opportunity to Join ORIC Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofORIC Pharmaceuticals, Inc. (Oricor the Company) (NASDAQ:ORIC) for violations of the securities laws.The investigation focuses on whether the Company issued false...
Business Wire·24d ago
News Placeholder
Oric Pharmaceuticals (NASDAQ:ORIC) Stock Price Up 6.5% - Still a Buy?
Oric Pharmaceuticals (NASDAQ:ORIC) Trading Up 6.5% - Here's Why...
MarketBeat·1mo ago
News Placeholder
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the fourteen brokerages that are currently covering the company...
MarketBeat·1mo ago
News Placeholder
Oric Pharmaceuticals (NASDAQ:ORIC) Trading 11.6% Higher - Time to Buy?
Oric Pharmaceuticals (NASDAQ:ORIC) Trading Up 11.6% - Here's Why...
MarketBeat·1mo ago
<
1
2
...
>

Latest ORIC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.